Loading...
Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC
Trigo Perez, JM Felip, E Brunsvig, P Helland, A Vinolas, N Aix, SP Costa, EC Gomez, MD Arriola, E Campelo, RG
Trigo Perez, JM
Felip, E
Brunsvig, P
Helland, A
Vinolas, N
Aix, SP
Costa, EC
Gomez, MD
Arriola, E
Campelo, RG
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Trigo Perez JM, Felip E, Brunsvig P, Helland A, Viñolas N, Ponce Aix S, et al. 1576P Efficacy results of selective AXL inhibitor bemcentinib with pembrolizumab following chemo in patients with NSCLC. Annals of Oncology. 2019;30(Supplement_5):649.